Nosebleed and drugs of ingredients of deferiprone (a real world drug study)
Summary:
Nosebleed is found among people who take drugs with ingredients of deferiprone, especially for people who are female, 50-59 old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 2,451 people who have side effects when taking drugs with ingredients of deferiprone from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Deferiprone, Ferriprox.
2,451 people reported to have side effects when taking drugs with ingredients of deferiprone.
Among them, 14 people (0.57%) have Nosebleed
What is Nosebleed?
Nosebleed (bleeding from nose) is found to be associated with 2,076 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.
Number of reports submitted per year:

Time on drugs with ingredients of deferiprone when people have Nosebleed *:
- < 1 month: 20 %
- 1 - 6 months: 80 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Nosebleed when taking drugs with ingredients of deferiprone *:
- female: 61.54 %
- male: 38.46 %
Age of people who have Nosebleed when taking drugs with ingredients of deferiprone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 16.67 %
- 20-29: 0.0 %
- 30-39: 8.33 %
- 40-49: 0.0 %
- 50-59: 50.0 %
- 60+: 25.0 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 35.71%
- Iron Overload: 5 people, 35.71%
- Infection: 5 people, 35.71%
- Diabetes: 4 people, 28.57%
- Essential Thrombocythaemia (chronic blood cancer): 4 people, 28.57%
- Gastric Ulcer (stomach ulcer): 4 people, 28.57%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 28.57%
- High Blood Pressure: 4 people, 28.57%
- Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 28.57%
- Muscle Spasms (muscle contraction): 4 people, 28.57%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Desferal: 6 people, 42.86%
- Augmentin: 5 people, 35.71%
- Siklos: 5 people, 35.71%
- Plaquenil: 5 people, 35.71%
- Metformin: 4 people, 28.57%
- Halcion: 4 people, 28.57%
- Jakafi: 2 people, 14.29%
- Folic Acid: 2 people, 14.29%
- Eliquis: 1 person, 7.14%
- Benadryl: 1 person, 7.14%
Other side effects people have besides Nosebleed *:
You may use this to check any potential undetected side effects.
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 50.00%
- Urinary Tract Infection: 6 people, 42.86%
- Weakness: 5 people, 35.71%
- Thrombocytopenia (decrease of platelets in blood): 4 people, 28.57%
- Anaemia (lack of blood): 3 people, 21.43%
- Blood Calcium Decreased: 3 people, 21.43%
- Blood Sodium Decreased: 3 people, 21.43%
- Protein Total Decreased: 3 people, 21.43%
- Hypersplenism (enlarged spleen and a decrease in one or more types of blood cells): 2 people, 14.29%
- Fever: 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of deferiprone, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on deferiprone. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bone Pain in Venlafaxine Hydrochloride, how severe and when it was recovered? - 3 seconds ago
- Constipation in Ortho Tri-Cyclen, how severe and when it was recovered? - 5 seconds ago
- Could Torsemide cause Sinus Bradycardia? - 10 seconds ago
- Could Claritin cause Interstitial Lung Disease? - 12 seconds ago
- Could Tamoxifen Citrate cause Sinusitis - Chronic? - 18 seconds ago
- Could Trileptal cause Upper Respiratory Tract Infection? - 23 seconds ago
- Drug interactions of Actemra and Remeron - 25 seconds ago
- Mirtazapine and Fatigue Aggravated for Men aged 60+ - 47 seconds ago
- Cervical Myelopathy and drugs of ingredients of penicillin v potassium - 52 seconds ago
- Allegra and Sleep Disorder for Men aged 50-59 - a minute ago